Hsuan-Chih Hsu

Hsuan-Chih Hsu


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2013 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
THTai-Lin Huang
Tai-Lin Huang
HHHsuan-Chih Hsu
Hsuan-Chih Hsu
HCHui-Chun Chen
Hui-Chun Chen
HLHsin-Ching Lin
Hsin-Ching Lin
Chih-Yen ChienChih-Yen Chien
Chih-Yen Chien
Cheng-Hsien LuCheng-Hsien Lu
Cheng-Hsien Lu
Background: Vascular abnormalities are the predominant histologic changes associated with radiation in nasopharyngeal carcinoma (NPC). This study examined if the duration after radiotherapy correlates with the progression of carotid intima-media thickness (IMT) and investigated its relationship with inflammatory markers. Methods: One hundred and five NPC patients post-radiotherapy for more than one year and 25 healthy control subjects were examined by B-mode ultrasound for IMT measurement at the far wall of the common carotid artery (CCA). Surrogate markers including lipid profile, HbA1c, and high sensitive C-reactive protein (hs-CRP) were assessed. Results: The IMT of CCA was significantly increased in NPC patients and carotid plaque was detected in 38 NPC patients (38/105, 36.2%). Significant risk factors for carotid plaques included age, duration after radiotherapy, and HbA1c levels. Age, duration after radiotherapy, hs-CRP, HbA1c, and platelet count positively correlated with IMT. The cut-off value of age and duration after radiotherapy for the presence of plaque was 52.5 years and 42.5 months, respectively. In NPC subjects, multiple linear regression analysis revealed that age, gender, duration after radiotherapy and platelet counts were independently associated with CCA IMT. After adjustments for age, gender and platelet counts, IMT increased in a linear manner with duration after radiotherapy. Conclusions: Radiation-induced vasculopathy is a dynamic and progressive process due to late radiation effects. Extra-cranial color-coded duplex sonography can be part of routine follow-up in NPC patients aged ≥50 years at 40 months post-radiotherapy.

30 January 2012 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
ENG-YEN HUANGENG-YEN HUANG
ENG-YEN HUANG
Yu-Jie HuangYu-Jie Huang
Yu-Jie Huang
CCChan-Chao Chanchien
Chan-Chao Chanchien
HLHao Lin
Hao Lin
CWChong-Jong Wang
Chong-Jong Wang
CWChang-Yu Wang
Chang-Yu Wang
To identify pretreatment carcinoembryonic antigen (CEA) levels as a risk factor for para-aortic lymph node (PALN) recurrence following concurrent chemoradiotherapy (CCRT) for cervical cancer.

1 January 2018 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
HLHsiao-Fei Lee
Hsiao-Fei Lee
JLJen-Hong Lan
Jen-Hong Lan
PCPei-Ju Chao
Pei-Ju Chao
HTHui-Min Ting
Hui-Min Ting
HCHui-Chun Chen
Hui-Chun Chen
Tsair-Fwu LEETsair-Fwu LEE
Tsair-Fwu LEE
Radiation-induced secondary malignancies for nasopharyngeal carcinoma: a pilot study of patients treated via IMRT or VMAT Hsiao-Fei Lee,1,2 Jen-Hong Lan,1,2 Pei-Ju Chao,1,2 Hui-Min Ting,1,2 Hui-Chun Chen,2 Hsuan-Chih Hsu,2 Tsair-Fwu Lee1–4 1Medical Physics and Informatics Laboratory of Electronics Engineering, National Kaohsiung University of Applied Sciences, Kaohsiung, Taiwan, Republic of China; 2Department of Radiation Oncology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan, Republic of China; 3Graduate Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China; 4Department of Radiation Oncology, Kaohsiung Yuan’s General Hospital, Kaohsiung, Taiwan, Republic of China Background: Patients treated with radiotherapy are at risk of developing a second cancer during their lifetime, which can directly impact treatment decision-making and patient management. The aim of this study was to qualify and compare the secondary cancer risk (SCR) after intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) in nasopharyngeal carcinoma (NPC) patients. Patients and methods: We analyzed the treatment plans of a cohort of 10 NPC patients originally treated with IMRT or VMAT. Dose distributions in these plans were used to calculate the organ equivalent dose (OED) with Schneider’s full model. Analyses were applied to the brain stem, spinal cord, oral cavity, pharynx, parotid glands, lung, mandible, healthy tissue, and planning target volume. Results: We observed that the OED-based risks of SCR were slightly higher for the oral cavity and mandible when VMAT was used. No significant difference was found in terms of the doses to other organs, including the brain stem, parotids, pharynx, submandibular gland, lung, spinal cord, and healthy tissue. In the NPC cohort, the lungs were the organs that were most sensitive to radiation-induced cancer. Conclusion: VMAT afforded superior results in terms of organ-at-risk-sparing compared with IMRT. Most OED-based second cancer risks for various organs were similar when VMAT and IMRT were employed, but the risks for the oral cavity and mandible were slightly higher when VMAT was used. Keywords: second cancer risk, organ equivalent dose, excess absolute risk, lifetime attributable risk, intensity modulated radiation therapy, volumetric modulated arc therapy

4 December 2012 in BMC Cancer
Verified
Journal Article
Open access
PDF file
Tsair-Fwu LEETsair-Fwu LEE
Tsair-Fwu LEE
PCPei-Ju Chao
Pei-Ju Chao
Hung-Yu WangHung-Yu Wang
Hung-Yu Wang
HHHsuan-Chih Hsu
Hsuan-Chih Hsu
PCPaoShu Chang
PaoShu Chang
WCWen-Cheng Chen
Wen-Cheng Chen
With advances in modern radiotherapy (RT), many patients with head and neck (HN) cancer can be effectively cured. However, xerostomia is a common complication in patients after RT for HN cancer. The purpose of this study was to use the Lyman–Kutcher–Burman (LKB) model to derive parameters for the normal tissue complication probability (NTCP) for xerostomia based on scintigraphy assessments and quality of life (QoL) questionnaires. We performed validation tests of the Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) guidelines against prospectively collected QoL and salivary scintigraphic data.

24 June 2010 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
Tsair-Fwu LEETsair-Fwu LEE
Tsair-Fwu LEE
PCPei-Ju Chao
Pei-Ju Chao
FFFu-Min Fang
Fu-Min Fang
TSTe-Jen Su
Te-Jen Su
Tsair-Fwu LEETsair-Fwu LEE
Tsair-Fwu LEE
HHHsuan-Chih Hsu
Hsuan-Chih Hsu
Dosimetric evaluations of single and multiple liver tumours performed using intensity-modulated helical tomotherapy (HT) were quantitatively investigated. Step-and-shoot intensity-modulated radiotherapy (SaS-IMRT) was used as a benchmark. Sixteen patients separated into two groups with primary hepatocellular carcinomas or metastatic liver tumours previously treated using SaS-IMRT were examined and re-planned by HT. The dosimetric indices used included the conformity index (CI) and homogeneity index (HI) for the planned target volume (PTV), max/mean dose, quality index (QI), normal tissue complication probability (NTCP), V(30 Gy), and V(50%) for the specified organs at risk (OARs). The monitor units per fraction (MU/fr) and delivery time were also analysed. For the single tumour group, both planning systems satisfied the required PTV prescription, but no statistical significance was shown by the indexes checking. A shorter delivery time and lower MU/fr value were achieved by the SaS-IMRT. For the group of multiple tumours, the average improvement in CI and HI was 14% and 4% for HT versus SaS-IMRT, respectively. Lower V(50%), V(30 Gy) and QI values were found, indicating a significant dosimetric gain in HT. The NTCP value of the normal liver was 20.27 +/- 13.29% for SaS-IMRT and 2.38 +/- 2.25% for HT, indicating fewer tissue complications following HT. The latter also required a shorter delivery time. Our study suggests dosimetric benefits of HT over SaS-IMRT plans in the case of multiple liver tumours, especially with regards sparing of OARs. No significant dosimetric difference was revealed in the case of single liver tumour, but SaS-IMRT showed better efficiency in terms of MU/fr and delivery time.